 Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati
Medanta Super Speciality Hospital performs Bhoomi Poojan of its Upcoming Hospital in Guwahati Firstsource and Monash University Sign Strategic MoU
Firstsource and Monash University Sign Strategic MoU Deep Diamond India Limited declares interim dividend of Rs. 0.10
Deep Diamond India Limited declares interim dividend of Rs. 0.10 Steelcast Ltd declares 2nd interim dividend of Rs. 0.36
Steelcast Ltd declares 2nd interim dividend of Rs. 0.36 Lancor Holdings Ltd gets favorable verdict from SC in commercial property case
Lancor Holdings Ltd gets favorable verdict from SC in commercial property case 
              Coromandel International's (CIL) Q1FY11 net sales remained flat at Rs15.5bn (-2.5% YoY). However, implementation of NBS policy and benefits from working capital management resulted in OPM expanding by 2.6x to 12%. Consequently net profit surged by 132.9% YoY to Rs1.2bn against our estimate of Rs950mn.
Outlook: We believe that fertiliser sector is going through a structural change where we will see lots of fresh investment driven by favorable policy environment in coming years, against lackluster last decade and hence we do not see any negativity arising out of govt intervention at regular intervals.
VALUATIONS AND RECOMMENDATION
We have increased our EPS estimate for FY11 and FY12 by 13% and 16% respectively on the back of higher volumes and better margins. At the CMP of Rs508, CIL trades at FY11 and FY12 P/E of 12.8x and 10.5x and EV/EBITDA of 8.4x and 6.6x respectively. We maintain our 'BUY' recommendation, with an increased target price of Rs581 (12x FY12E EPS), on the back of higher multiple post-NBS, a premium to Urea players.